No Data
Jieya Co., Ltd. (301108.SZ) issued a profit warning, expecting a net income of 15 million yuan to -22.5 million yuan for the year 2024, a year-on-year decrease of 86.98% to 80.47%.
Jieya Co., Ltd. (301108.SZ) released the annual performance forecast for 2024, and the company expects the annual net profit for 2024 to be...
Jieya Co., Ltd.: 2024 Annual Results Forecast
Jieya Co., Ltd. (301108.SZ) plans to establish a subsidiary in the USA and invest in the construction of a wet wipe production base.
On December 27, Gelonghui reported that Jieya Co., Ltd. (301108.SZ) announced that based on the current international trade situation, changes in the Global supply chain, and future Business development plans, it intends to establish a wholly-owned subsidiary, Joyalways Corporation (tentatively named "USA subsidiary", final name subject to local approval), through its wholly-owned USA subsidiary, Joyalways Investment Corporation, and invest in the construction of a wet wipes production base. The total investment for the project is预计约0.616 billion RMB (approximately 85 million USD).
Tongling Jieya Biologic Technology Co., Ltd.'s (SZSE:301108) Business Is Trailing The Market But Its Shares Aren't
Jieya Co., Ltd. (301108.SZ): plans to permanently use 0.19 billion yuan of oversubscribed funds to supplement working capital.
On December 9th, Gelonghui announced that Jieya Co., Ltd. (301108.SZ) held the 22nd meeting of the fifth board of directors and the 20th meeting of the fifth board of supervisors on December 9, 2024, respectively reviewing and approving the proposal regarding the permanent supplementation of working capital using part of the oversubscribed funds, agreeing to use 0.19 billion yuan of oversubscribed funds to permanently supplement working capital. This proposal still needs to be submitted for approval at the company's shareholder meeting.
Jieya Co., Ltd. (301108.SZ): Invested in the establishment of a wholly-owned subsidiary in the usa and completed the business registration.
On November 21, Gelonghui reported that Jeya Co., Ltd. (301108.SZ) announced the establishment of a wholly-owned subsidiary, Joyalways Investment Corporation (hereinafter referred to as "USA Subsidiary"), in Delaware, USA, with its own funds to meet the business development needs of the company, deepen cooperation with overseas customers, and improve the stability and efficiency of the international supply chain, in line with the company's actual situation. The main business of the USA Subsidiary will be to engage in import and export trade and serve as an investment platform for overseas investment activities. Recently, the company received the registration certificate for the USA Subsidiary.
Returns On Capital Signal Tricky Times Ahead For Tongling Jieya Biologic Technology (SZSE:301108)